INVOLYS S.A. (CBSE:INV)
158.80
-2.10 (-1.31%)
At close: Jul 29, 2025
Achilles Therapeutics Revenue
In the year 2024, INVOLYS had annual revenue of 46.89M MAD with 1.49% growth. INVOLYS had revenue of 26.51M in the half year ending December 31, 2024, with 11.37% growth.
Revenue
46.89M
Revenue Growth
+1.49%
P/S Ratio
1.30
Revenue / Employee
571.80K
Employees
82
Market Cap
60.78M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 46.89M | 688.50K | 1.49% |
Dec 31, 2023 | 46.20M | -4.11M | -8.16% |
Dec 31, 2022 | 50.30M | -1.53M | -2.95% |
Dec 31, 2021 | 51.83M | 8.50M | 19.61% |
Dec 31, 2020 | 43.33M | -4.08M | -8.60% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Attijariwafa bank | 31.03B |
Itissalat Al-Maghrib (IAM) | 36.48B |
TAQA Morocco | 10.86B |
Managem | 8.86B |
Banque Centrale Populaire | 20.05B |
Société d'Exploitation des Ports | 5.01B |
Bank of Africa | 16.06B |
LafargeHolcim Maroc | 8.15B |